Style
CoreTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Cogent Biosciences Inc(COGT) | 343,284 | $13.3M | 8.39% |
| 2 | Axsome Therapeutics Inc.(AXSM) | 53,916 | $13.2M | 8.33% |
| 3 | Genmab A/S(GMAB) | 430,600 | $11.8M | 7.47% |
| 4 | Celldex Therapeutics Inc New(CLDX) | 287,583 | $10.7M | 6.76% |
| 5 | Trevi Therapeutics Inc(TRVI) | 524,224 | $9.8M | 6.17% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 91.79% | 92.14% | +0.35% |
| Unclassified | 8.21% | 7.86% | -0.35% |
Quarter-over-quarter weight changes by market cap
| Revolution Medicines Inc(RVMD) |
| 51,053 |
| $9.6M |
| 6.04% |
| 7 | Definium Therapeutics Inc(DFTX) | 188,282 | $8.9M | 5.59% |
| 8 | VIR Biotechnology Inc(VIR) | 853,685 | $8.7M | 5.49% |
| 9 | Immunovant Inc(IMVT) | 208,368 | $8.0M | 5.07% |
| 10 | Urogen Pharma LTD(URGN) | 191,313 | $7.0M | 4.45% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Small Cap | 33.09% | 37.27% | +4.18% |
| Mid Cap | 29.11% | 32.46% | +3.35% |
| Large Cap | 26.19% | 18.17% | -8.02% |
| Unclassified | 8.21% | 7.86% | -0.35% |
| Micro Cap | 3.4% | 4.25% | +0.85% |
Quarter-over-quarter position changes